Genomics and Population Health Challenges for the Public Health Community Dr Ron Zimmern MA, FRCP, FFPHM Director, Public Health Genetics Unit, Cambridge.

Slides:



Advertisements
Similar presentations
WCDR Thematic Panel Governance: Institutional and Policy Frameworks for Risk Reduction Annotated Outline UNDP – UNV – ProVention Consortium – UN-Habitat.
Advertisements

4 th Meeting of the EC International Dialogue on Bioethics Copenhagen, June 19 th, 2012 Large research and medical databases in clinical and research multi-centred.
Public Health Essential Service #2
UCET Northern Ireland 2011 Teaching Scotlands Future TEACHING SCOTLANDS FUTURE Graham Donaldson CB.
Professor Dave Delpy Chief Executive of Engineering and Physical Sciences Research Council Research Councils UK Impact Champion Competition vs. Collaboration:
Assessing Excellence with Impact Ian Diamond ESRC.
Implementing NICE guidance
NIHR Delivering Better Health 20 November 2012, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
Towards a New R&D Strategy A blueprint for R&D in Health and Social Care Noreen Caine Deputy Director of R&D, DH NHS R&D Forum Annual Conference May 2005.
E.g Act as a positive role model for innovation Question the status quo Keep the focus of contribution on delivering and improving.
Principles & Framework
Meaningful Patient Involvement In FP7 Research Nicola Bedlington Meaningful Patient Involvement In FP7 Research Nicola Bedlington Open Information Day.
Local Education and Training Boards Adam C Wardle Managing Director, Yorkshire and the Humber Local Education and Training Board.
Welcome to the NIHR Peter Knight, Deputy Director Research Contracting, Information Intelligence and Stakeholder Engagement NIHR Trainees Meeting Leeds.
10 th October 2013 The delivery of 21 st century services – the implications for the evolution of the Healthcare Science workforce Joan Fletcher.
CUHP Cambridge University Health Partners (CUHP) unites a world-leading University and three high- performing NHS Foundation Trusts centred on the Cambridge.
Public Health and Healthy Local Government Maggi Morris Executive Director of Public Health Central Lancashire.
Information and Communication Technology Research Initiative Supporting the self management of obesity: The role of ICTs University.
Health Stakeholder Consultation Event Frances Spillane, Assistant Secretary General Department of Health 11 March 2015.
March Back to Basics, 2015 POPULATION HEALTH Dr. Nicholas Birkett School of Epidemiology, Public Health and Preventive Medicine.
Degree Programs in Public Health: A Canadian Perspective Sylvie Stachenko Dean, School of Public Health Global Summit on Education and Training in Heart.
WHO GLOBAL ALCOHOL STRATEGY
Competency Assessment Public Health Professional (2012)-
LIMITLESS POTENTIAL | LIMITLESS OPPORTUNITIES | LIMITLESS IMPACT Copyright University of Reading IMPACT AND THE SCIENCES Anthony Atkin (Research Impact.
Frameworks for change in health & sickness organisations Sandra Dawson Cambridge International Health Leaders Programme 2006.
Essential Service # 7:. Why learn about the 10 Essential Services?  Improve quality and performance.  Achieve better outcomes – improved health, less.
Outcomes of Public Health
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.
Developing a ‘Bench to Bedside’ Commercial Collaboration Jo Chambers.
Health Sciences and Practice Subject Centre Mental Health Special Interest Group 22 nd April 2009 Tracy Lindsay & Jenny Oates.
Health inequalities post 2010 review – implications for action in London London Teaching Public Health Network “Towards a cohesive public health system.
MANIFESTO FOR RESPONSIBLE EUROPEAN MANAGEMENT EUROCADRES’ Conference Nov 2003 Dirk Ameel.
Expert Input : Review of Days 1 & 2 1. Forum Days 1 & 2 2 Overview of Days’ 1 & 2 Themes, Sessions, and Guiding Questions.
The Innovative Medicines Initiative (IMI) High level the IMI Concept, Strategic Research Agenda and Call topics Eva Lindgren.
Welcome to SURF 09 Involving Patients and the Public in HCAI Research.
Learning Outcomes of the SCPHN Programme & How they Link to Practice.
Taking forward the Next Stage Review Clinical leadership and networks in the North.
National Museums Liverpool Presentation by: Claire Benjamin Deputy Director Education and Visitors National Museums Liverpool.
Ms Rebecca Brown Deputy Director General, Department of Health
Towards a European network for digital preservation Ideas for a proposal Mariella Guercio, University of Urbino.
Dr Caroline Gamlin Director of Public Health NHS Somerset World Class Commissioning.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
1 Post-Genomics and the Future of Human Societies: a Foresight Approach Excerpts from “ DNA Analysis for Human Health in the Post- Genomic Era - An APEC-wide.
FAMILY HEALTH PROMOTION
4/24/2017 Health and Social Care Reform in Greater Manchester Developing a commissioning strategy for Primary Care Rob Bellingham — Director of Commissioning.
SSHRC - ERA - SAGE Workshop Research on the Ethical, Legal and Societal Aspects of Human Genomics: North America Denise Avard PhD Director of Research.
Horizon Scanning: future skills and competences of the health workforce in Europe MATT EDWARDS and JOHN FELLOWS WP6, EU JA on Health Workforce Planning.
Establishing National Technology Development and Transfer Systems
OECD Innovation Strategy Deliverables, policy implications and next steps Miriam Koreen OECD-France workshop 7 December 2009.
Caring, Ethics, Science. Caring Physicians of the World (CPW) Medical Leadership Communication and Medical Advocacy Course Monday, 2 nd May.
R&D Report to SL&M Board 17 September 2002 Graham Thornicroft Director of Research & Development Gill Dale Research & Development Manager.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
Science & Technology for National Progress in African Region: Highlights of Regional Strategy and Action Professor Gabriel B. Ogunmola, FAS President,
A look into current and future trends in national policies for eHealth and Innovation in the WHO European Region Clayton Hamilton, eHealth and Innovation.
Dr. Carissa F. Etienne Director PAHO/WHO UNIVERSAL HEALTH COVERAGE Building a path forward in the Region of the Americas 3 December 2013.
The Workforce, Education Commissioning and Education and Learning Strategy Enabling world class healthcare services within the North West.
Local Education and Training Boards Tim Gilpin Director of Workforce and Education NHS North of England.
03/20161 Back to Basics, 2016 POPULATION HEALTH Dr. Nicholas Birkett School of Epidemiology, Public Health and Preventive Medicine.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
NHS Research & Development North West Dr Lynne Goodacre Assistant Director NHS Health Education North West.
Genetics as a determinant of health: new challenges for epidemiology
Developing the role of Clinical Research Practitioners in the NHS:
SSHRC - ERA - SAGE Workshop Research on the Ethical, Legal and Societal Aspects of Human Genomics: North America Denise Avard PhD Director of Research.
Impact and the Physical Sciences
Integrating Genetics & Genomics Education into Nursing Workforce
The new Professional Leadership Body: supporting advanced and specialist practice Dr Catherine Duggan.
Integrating Genetics & Genomics Education into Nursing Workforce
NJCU College of Education
Research for all Sharing good practice in research management
Advancing South-South Cooperation for Effective Implementation of
Presentation transcript:

Genomics and Population Health Challenges for the Public Health Community Dr Ron Zimmern MA, FRCP, FFPHM Director, Public Health Genetics Unit, Cambridge Royal College of Physicians, London 26 January 2006

Contents of Talk 1.Intellectual challenges of public health genetics 2.Practical challenges and public health action 3.Bellagio and the international dimension

Intellectual Challenges of Public Health Genetics

The Basic Thesis Public health practice in the twenty first century can no longer ignore the knowledge derived from genetic and molecular science. An understanding of the cellular mechanisms of disease will be as important to the public health community as an understanding of the social determinants of health.

Intellectual Challenges 1.Understanding basic genetics, cell and molecular biology and their complexity 2.Understanding that genetic factors are important health determinants and the implications of gene-gene and gene-environment interaction 3.Understanding that genetic influences do not entail determinism 4.Understanding the basic principles of genetic epidemiology and their implications for population health 5.Understanding the complementary nature of high risk and population approaches to disease prevention 6.Understanding the ethical, legal, social and policy implications of genetics and molecular science

Genetic BiologicalPhysical Political Social Behavioural Genetic Endowment Natural Environment Structural Environment Individual Behaviour INDIVIDUALS POPULATIONS Determinants of Health

Gene-environment Interaction ‘Totally’ Genetic ‘Totally’ Environmental Struck by lightning Motor vehicle accident Duchenne muscular dystrophy Cystic fibrosis Heart disease Cancer Schizophrenia Diabetes Obesity Asthma Rheumatoid arthritis PKU Alzheimers Fragile X Autism TB Meningococcus Multiple sclerosis

Complexity in Genetic Science 1.Gene-gene interaction 2.Control of transcription 3.Alternative splicing 4.Post translational modification 5.Temporal effects

Practical Challenges and Public Health Action

Practical Challenges 1.Leadership in public health genetics 2.Knowledge integration and evidence synthesis 3.Service development and evaluation 4.Education and training 5.Informing public policy 6.Genomics and global health

Leadership in Public Health Genetics 1.Developing awareness genetic literacy 2.Building capacity specialist public health geneticists 10 to 12 in UK with detailed understanding of issues informing intelligent commissioning 3.Establishing networks national and international SOGPAPH and GRAPHInt

Knowledge Base Genetics and Molecular Science Public Health Sciences Humanities and Social Sciences Technical Skills Health Needs Assessment Programme Planning Data Analysis Review and Evaluation Management Financial Planning Political Sensitivity Ethnicity Cultural differences Interpersonal Skills Personal Development THE SCIENCE THE ART Professional Competence PROFESSIONAL COMPETENCE IN PUBLIC HEALTH GENETICS

Genetic and Population Sciences and the Humanities GENETIC SCIENCE Basic concepts of mendelian genetics Family histories and pedigrees Risk assessment and communication Principles of genetic epidemiology Principles of molecular genetics Genetic testing and screening Genetics of common disorders Gene-environment interaction HUMANITIES Sociology Anthropology Law Economics Ethics Metaphysics and epistemology Theology Political philosophy POPULATION SCIENCES Epidemiology Biostatistics Environmental health sciences Infectious diseases Social and behavioural sciences Health economics Health services research Management science Information science

Service Development and Evaluation 1.Evaluation and regulation of genetic tests and biomarkers 2.Integration of genetic science into mainstream clinical specialties 3.Organisational issues for laboratory genetics in the context of pathology modernisation 4.Ensuring intelligent commissioning of genetic services 5.Genetics in primary care 6.Genetic screening programmes 7.Genetic services and the commercial sector

National Strategy for Genetics Education Strategy for increasing the knowledge and understanding of genetics across the health care professions – genetic literacy Commitment of Wellcome Trust to background report Strategy commissioned jointly by Wellcome Trust and DH Establishment of the National Genetics Education and Development Centre

Six Policy Issues 1.The regulatory framework Ensuring a balanced approach 2.Educational strategies Health professionals, general public 3.The science base Science infrastructure 4.Commercial considerations Entrepreneurship, IPR and public private partnerships 5.Information and confidentiality Personal data, human tissue, stem cells,gene therapy 6.Financial framework for health Cost pressures, impact on NHS, health economics

UK Policy Context 1.Our Inheritance, Our Future – Realising the potential of genetics in the NHS (Jun 03) 2.Strengthening Clinical Research (Oct 03) 3.Lambert Review of Business University Collaborations (Dec 03) 4.Bioscience 2015: Improving National Wealth, Improving National Health (Nov 03) 5.Securing Good Health for the Whole Population: Wanless Report (Feb 04) 6.Science and Innovation: A Ten Year Investment Framework (Mar 04) 7.Research for Patient Benefit Working Party (Mar 04) 8.Public Health Sciences: Challenges and Opportunities (Mar 04) 9.Choosing Health: Making Healthier Choices Easier (Nov 04) 10.NHS Improvement Plan: Putting People at the Heart of Public Services (Nov 04) 11.Better Health Through Partnership. HITF (Nov 04) 12.Creating a Patient Led NHS (Mar 05) 13.Best Research for Best Health: A New NHS Research Strategy (Jul 05) 14.Modernising Pathology: Building a Service Responsive to Patients (Sep 05)

Impact of UK Policy Context 1.Importance of genetics and molecular science research 2.Need for a vibrant research base and research capacity 3.Imperative of strong and well developed links between academia, the NHS and the commercial sector 4.Importance of the NHS as a unique resource for clinical trials and all forms of clinical research including epidemiological studies and health services research 5.Growing importance of public health and preventive medicine 6.Need for appropriate and balanced regulatory regimes

Bellagio and the International Dimension

The Bellagio Initiative 18 experts from UK, France, Germany, USA and Canada Funded by Rockefeller Foundation Aims To explore the possibility of establishing an international network to promote the goals of public health genetics/genomics To share knowledge and resources To ensure equitable access to the benefits of genome-based knowledge by all, including those in developing countries

Questions and Issues 1.What are the fundamental concepts of public health genetics/genomics? 2.Can ‘personalised medicine’ be reconciled with the population- level goals of public health? 3.What are the key ethical, legal and social issues and how can they be addressed? 4.How can different disciplines work together to achieve shared goals? 5.What genetics competencies do health professionals need?

The Bellagio Statement The responsible and effective translation of genome-based knowledge and technologies for the benefit of population health

The Enterprise

GRAPH Int GRAPH Int is an international collaboration that facilitates the responsible and effective translation of genome-based knowledge and technologies into public policies, programmes and services for the benefit of population health Aims To provide an international forum for dialogue and collaboration To promote relevant research To support the development of an integrated knowledge base To promote education and training To encourage communication an engagement with the public and other stakeholders To inform public policy Official Launch Genomics and Public Health Montreal, Canada 4-7 June